The Company announced the new-elected members
of the Audit Committee
Date of events
2022/05/27
To which item it meets
paragraph 6
Statement
1.Date of occurrence of the change:2022/05/27
2.Name of the functional committees:the Audit Committee
3.Name of the previous position holder:
Chien-Huang Lin, Chih-Li Wang, Sonny Wang
4.Resume of the previous position holder:
Chien-Huang Lin: President, Taipei Medical University
Chih-Li Wang: Accountant, Moores Rowland CPAs
Sonny Wang: Ex-Secretary, Taiwan Corporate Governance Association
5.Name of the new position holder:
Chien-Huang Lin, Ming-Daw Chang, Chih-Li Wang
6.Resume of the new position holder:
Chien-Huang Lin: President, Taipei Medical University
Ming-Daw Chang: Chairman, Bank of Panhsin
Chih-Li Wang: Accountant, Moores Rowland CPAs
7.Circumstances of change (Please enter "resignation", "dismissal",
"term expired", "death" or "new appointment"):term expired
8.Reason for the change:tenure expired
9.Original term (from __________ to __________):108/06/13 ~111/06/12
10.Effective date of the new member:2022/05/27
11.Any other matters that need to be specified:None
Attachments
Original Link
Original Document
Permalink
Disclaimer
PharmaEngine Inc. published this content on 27 May 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 27 May 2022 10:41:57 UTC.
PharmaEngine, Inc. is a Taiwan-based company principally engaged in the development of new drugs, as well as the licensing and sales of products. The Company is developing three new anti-cancer drugs under the brand of ONIVYDE, which are nal-IRI, MM-398 and PEP02. The Company distributes its products mainly to overseas markets,
PHARMAENGINE, INC. 
